Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CFO Christopher Astle sold 4,563 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $10.65, for a total transaction of $48,595.95. Following the completion of the sale, the chief financial officer now owns 7,934 […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the transaction, the insider now directly owns 7,367 […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) CEO Kenneth Galbraith sold 5,706 shares of the company’s stock in a transaction on Monday, January 8th. The stock was sold at an average price of $11.22, for a total value of $64,021.32. Following the transaction, the chief executive officer now directly owns 23,762 shares in the company, […]
Zymeworks Inc. (NYSE:ZYME – Get Free Report) insider Paul Andrew Moore sold 2,339 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $11.22, for a total transaction of $26,243.58. Following the completion of the sale, the insider now directly owns 7,367 shares of […]
Company well-positioned for further progress and broadening of R&D pipelineCash resources of approximately $455 million as of December 31, 2023 Expected cash runway, including proceeds from recent...